Ignite Creation Date:
2024-05-05 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00431795
Status:
TERMINATED
Last Update Posted:
2013-02-13
First Post:
2007-02-05
Brief Title:
Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast Cancer
Sponsor:
Hellenic Oncology Research Group
Organization:
Hellenic Oncology Research Group
Organization Data
Organization:
Hellenic Oncology Research Group
Class:
OTHER
Study ID:
CT0312
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hellenic Oncology Research Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| University Hospital of Crete | OTHER |